Decision

UK REACH authorisation for Abbott Laboratories Ltd, 3 July 2024

Decision on application for authorisation under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 12 August 2024

Documents

UK REACH authorisation for Abbott Laboratories Ltd

PDF, 251 KB, 8 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisation under UK REACH. 

Substance name 

4-(1,1,3,3,tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).

Authorised use

Professional use as a surfactant, in wash buffer components used in conjunction with fluorescence in situ hybridisation (FISH) test kits and/or their laboratory developed test (LDT) equivalents, in clinical diagnostic use for medical analysis of human tissue and blood samples to identify characteristic genetic abnormalities related to specific disease conditions.  

Holder of the authorisation and authorisation number 

Abbott Laboratories Ltd (UKREACH/24/07/0). 

Date of decision 

3 July 2024.

Published 12 August 2024